6 min. Read

Is it enough? Early MAC pricing for new digital mental health treatment code

Issue 244

Welcome back to E&O: SaMD, a paying subscribers-only weekly newsletter focused on the world of digital pharma products, prescription digital therapeutics and other FDA-regulated digital health.

E&O: Software as a Medical Device

Here's a

Sign-up for the newsletter for access.

It's a good one, too.

This article is for Exits & Outcomes subscribers only. Subscribe now to get the weekly newsletter. Enter your email below to subscribe today!

Newsletters

Six years of Oura’s financials: Revenue, profits, marketing spend and more

5.22.26

4 min. Read

ACCESS Model’s first dropout? Plus: A few new participants

5.08.26

6 min. Read

Are these Utah’s next four AI experiments? Plus: More on the Utah Pharmacy Board’s questions about Doctronic

4.17.26

9 min. Read

Emails show how Doctronic’s AI pilot blindsided Utah’s Medical Board

4.10.26

13 min. Read

Quiet funding rounds. Plus: Digital health-related clinical trial round-ups

3.20.26

5 min. Read

Details: Vida Health’s brief GLP-1 rollout in Mass. Plus: CMS says Freespira not DME

3.13.26

7 min. Read

ACCESS Model’s shockingly low payments. DMHT Rx count.

2.13.26

7 min. Read

HLTH acquisition price. Estimating Pomelo Care pricing, revenue, and more

1.09.26

7 min. Read

CMS to pay for ADHD DTx. More PFS notes. Two FDA De Novos.

11.07.25

6 min. Read

Pricing for Sword Health, Hinge Health, Joint Academy in the UK.

10.31.25

7 min. Read

Is it enough? Early MAC pricing for new digital mental health treatment code

E&O: Software as a Medical Device

Sign-up for the newsletter for access.

E&O's weekly newsletter.